ColgatePalmolive (CL)
(Delayed Data from NYSE)
$99.04 USD
-0.93 (-0.93%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $98.65 -0.39 (-0.39%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$99.04 USD
-0.93 (-0.93%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $98.65 -0.39 (-0.39%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth D Momentum D VGM
Zacks News
Church & Dwight Sales to Gain on International Unit & More
by Zacks Equity Research
Church & Dwight's (CHD) top line has been impressive for a while, gaining from strong Consumer International unit, buyouts and innovation.
Newell Loses 22% YTD: Can Its Transformation Plan Aid Stock?
by Zacks Equity Research
Newell's (NWL) dismal sales surprise trend can be attributed to lower core sales and adverse foreign currency. Nevertheless, its Transformation Plan appears encouraging.
Will Archer Daniels' Strategic Growth Efforts Drive Stock?
by Zacks Equity Research
Archer Daniels' (ADM) soft Carbohydrate Solutions segment is concerning. Nevertheless, the company's growth efforts such as the Readiness program are commendable.
Here's Why Colgate (CL) Deserves a Place in Your Portfolio
by Zacks Equity Research
Colgate (CL) exhibits strong surprise trend, owing to accelerated investments in brands, higher pricing and strong innovation along with expansion in new markets and channels.
Factors Likely to Influence Brown-Forman's (BF.B) Q4 Earnings
by Zacks Equity Research
Brown-Forman's (BF.B) Q4 results are likely to benefit from robust brand portfolio. However, tariff-related costs are hurting underlying net sales and gross margin.
Colgate-Palmolive (CL) Up 3.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Procter & Gamble (PG) Surges 47% in a Year: More Room to Run?
by Zacks Equity Research
Procter & Gamble (PG) stock reflects immense growth potential, backed by ongoing initiatives to improve productivity. However, strained margins and currency headwinds remain deterrents.
Here's Why Colgate-Palmolive (CL) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Colgate-Palmolive (CL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Church & Dwight (CHD) Q1 Earnings Beat, Organic Sales Up
by Zacks Equity Research
Church & Dwight's (CHD) earnings and sales improve in Q1. Management raises net sales view, considering the buyout of FLAWLESS.
Colgate (CL) Hits 52-Week High: What's Behind the Rally?
by Zacks Equity Research
Colgate's (CL) investments in brands, higher pricing and strong innovation along with expansion in new markets and channels bode well. Also, the company is on track with its savings program.
Colgate (CL) Q1 Earnings & Sales Top Estimates, Stock Up
by Zacks Equity Research
Colgate (CL) delivers top and bottom-line beat in first-quarter 2019, benefiting from favorable pricing and volume growth. However, adverse currency remains a hurdle.
UN or CL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UN vs. CL: Which Stock Is the Better Value Option?
Factors Likely to Shape Colgate's (CL) Q1 Earnings Outcome
by Zacks Equity Research
Colgate's (CL) growth efforts make us confident that it will likely retain the robust bottom-line surprise trend. However, soft margins and adverse currency may be deterrents.
Earnings Preview: Colgate-Palmolive (CL) Q1 Earnings Expected to Decline
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Whirlpool (WHR) Rewards Shareholders With 4.3% Dividend Hike
by Zacks Equity Research
Whirlpool (WHR) raises its quarterly cash dividend by 5 cents to $1.20 per share.
Procter & Gamble (PG) Boosts Shareholder Value, Hikes Dividend
by Zacks Equity Research
Procter & Gamble (PG) retains a commitment to reward shareholders by raising quarterly dividend by 4% to 74.59 cents per share.
Newell Down 20% in 3 Months: Is a Turnaround on the Cards?
by Zacks Equity Research
Newell's (NWL) dismal sales surprise trend can be attributed to lower core sales and adverse foreign currency. Nevertheless, its Transformation Plan is encouraging.
The Zacks Analyst Blog Highlights: Boeing, Lockheed Martin and Anthem
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Boeing, Lockheed Martin, Anthem, Colgate-Palmolive and Delta Air Lines
Top Stock Reports for Boeing, Lockheed Martin & Anthem
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Boeing (BA), Lockheed Martin (LMT) and Anthem (ANTM).
UN or CL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UN vs. CL: Which Stock Is the Better Value Option?
P&G Witnesses Balanced Risk-Reward: Stock Up 31.2% in a Year
by Zacks Equity Research
P&G (PG) gains from initiatives to improve product, packaging & marketing efforts, and productivity & cost-saving plans. However, strained margins and currency headwinds remain concerns.
Church & Dwight (CHD) Up 20% in 6 Months: Will Momentum Stay?
by Zacks Equity Research
Church & Dwight (CHD) flaunts an impressive sales trend, owing to the strong Consumer International unit, focus on acquisitions and brand enhancement initiatives. However, margin woes remain.
Can Colgate's (CL) Cost-Savings Programs Offset Margin Woes?
by Zacks Equity Research
Colgate (CL) struggles with strained margins for quite a while now. Nevertheless, the company's cost-savings program appears encouraging.
Colgate (CL) Enhances Shareholder Returns, Hikes Dividend
by Zacks Equity Research
Colgate (CL) increases quarterly dividend from 42 cents per share to 43 cents. The company is also progressing well with the Global Growth and Efficiency Program.
UN vs. CL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UN vs. CL: Which Stock Is the Better Value Option?